Concepedia

Anastasia G. Daifotis

AG

17

Publications

3.7K

Citations

17

H-Index

1990

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Yale University

Hôpital Edouard Herriot

Centre hospitalier universitaire de Québec

Ghent University Hospital

Anastasia G. Daifotis is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, endocrinology, and bone health.

Top concepts

Publications per year

1990–2013

17

Publications

17

Alendronate for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis

Kenneth G. Saag, Ronald Emkey, Thomas J. Schnitzer et al. · New England Journal of Medicine · 1998 · 1.3K citations · Full text

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial

Jonathan D. Adachi, Kenneth G. Saag, P. D. Delmas et al. · Arthritis & Rheumatism · 2001 · 547 citations

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

Nicole Sherry, William Hagopian, Johnny Ludvigsson et al. · The Lancet · 2011 · 484 citations

, , +7

Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes

William Hagopian, Robert J. Ferry, Nicole Sherry et al. · Diabetes · 2013 · 239 citations · Full text

, , +15

Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development

John J. Wysolmerski, James McCaughern-Carucci, Anastasia G. Daifotis et al. · Development · 1995 · 205 citations

Rows per page

1–5 of 17